New Caledonia vs Qatar: The number of people with susceptibility test result for rifampicin
New Caledonia
100
in 2021
Qatar
100
in 2021
New Caledonia rank
2nd
Qatar rank
2nd
The number of people with susceptibility test result for rifampicin over time
- New Caledonia
- Qatar
How they compare
New Caledonia currently reports 100 against 100 in Qatar, a difference of 0.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Qatar ahead.
New Caledonia ranks 2nd and Qatar ranks 2nd of 146 countries.
New Caledonia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | New Caledonia | Qatar | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 100 | 83.79 | 16.21 | New Caledonia |
| 2020s | 100 | 100 | 0 | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, New Caledonia or Qatar?
- New Caledonia, at 100 against 100 in Qatar as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between New Caledonia and Qatar?
- 0, with New Caledonia ahead.
- How many years of comparable data are there for New Caledonia and Qatar?
- 5 years are reported by both, from 2017 to 2021.
- How do New Caledonia and Qatar rank globally for the number of people with susceptibility test result for rifampicin?
- New Caledonia ranks 2nd and Qatar ranks 2nd of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.